Quach, H.
Nooka, A.
Samoylova, O.
Venner, C.P.
Facon, T.
Spencer, A.
Usmani, S.Z.
Weisel, K.
Mateos, M.
Kim, K.
Grosicki, S.
Suzuki, K.
Delimpasi, S.
Obreja, M.
Zahlten-Kumeli, A.
This article is maintained by: Elsevier
Article Title: CARFILZOMIB, DEXAMETHASONE, AND DARATUMUMAB VERSUS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 CANDOR STUDY BY NUMBER OF PRIOR LINES OFTHERAPY AND PRIOR THERAPIES
Journal Title: Hematology, Transfusion and Cell Therapy
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2020.10.425
Content Type: simple-article
Copyright: Copyright © 2020 Published by Elsevier Editora Ltda.